Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.42 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.40 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9614394 | 0.93 | CA12 (0.43) | HSD17B10SLC2A1CTDSP1ALDH1A1MEN1 | |
| SCHEMBL19274350 | 0.92 | HSD17B10 (0.40) | HSD17B10SLC2A1CTDSP1ALDH1A1MEN1 | |
| SCHEMBL17695444 | 0.88 | HSD17B10 (0.39) | HSD17B10SLC2A1CTDSP1ALDH1A1MEN1 | |
| SCHEMBL9614432 | 0.84 | TRPV4 (0.49) | HSD17B10SLC2A1ALDH1A1MEN1KMT2A | |
| SCHEMBL31187734 | 0.84 | S1PR3 (0.49) | SLC2A1ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL4778946 | 0.84 | S1PR3 (0.49) | SLC2A1ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL31187737 | 0.84 | S1PR3 (0.49) | SLC2A1ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL4783019 | 0.84 | S1PR3 (0.49) | SLC2A1ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL3104434 | 0.84 | S1PR3 (0.49) | SLC2A1ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL31187743 | 0.84 | S1PR3 (0.49) | SLC2A1ALDH1A1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170240570-A1 | NOVEL SMALL MOLECULE ANTICANCER AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2017-08-24 | — | — | US | disclosed |
| US-9513284-B2 | Pyrenyloxysulfonic acid fluorescent agents | Life Technologies Corporation (US) | 2016-12-06 | — | — | US | disclosed |
| US-20140193926-A1 | PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS | Life Technologies Corporation (US) | 2014-07-10 | — | — | US | disclosed |
| US-8268886-B2 | Pyrenyloxysulfonic acid fluorescent agents | Life Technologies Corporation (US) | 2012-09-18 | — | — | US | disclosed |
| US-20120045848-A1 | PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS | Life Technologies Corporation (US) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120045848-A1 | PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS | NOP56, ANXA5, ANXA6 | HSD17B10 3961/4885SLC2A1 4860/4885CTDSP1 2694/4885 |
| US-20170240570-A1 | NOVEL SMALL MOLECULE ANTICANCER AGENTS | MKI67, TP53, PCNA | HSD17B10 2573/4885SLC2A1 2297/4885CTDSP1 569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.